Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 18 - Minutes of Proceedings - May 30, 2012

OTTAWA, Wednesday, May 30, 2012
(42)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:14 p.m., in room 2, Victoria Building, the Honourable Kelvin K. Ogilvie, Chair, presiding.

Members of the committee present: The Honourable Senators Callbeck, Cordy, Dyck, Eggleton, P.C., Hubley, Martin, Ogilvie, Patterson, Seidman, Seth, Verner, P.C., and Wallace (12).

In attendance: Sonya Norris, Analyst, Parliamentary Information and Research Service, Library of Parliament.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Thursday, November 17, 2011, the committee continued its study on prescription pharmaceuticals in Canada. (For complete text of the order of reference, see proceedings of the committee, Issue No. 12.)

WITNESSES:

Clinical Trials Ontario:

Ronald Heslegrave, Executive Director.

Canadian Association of Research Ethics Board:

Sharon Freitag, Past President.

Ontario Institute for Cancer Research:

Janet Manzo, Executive Director, Ontario Cancer Research Ethics Board;

Dr. Raphael Saginur, Chair, Ontario Cancer Reseach Ethics Board Governance Committee.

The chair made a statement.

Dr. Saginur, Ms. Freitag and Mr. Heslegrave each made a statement and, together with Ms Manzo, answered questions.

At 6:09 p.m., the committee adjourned to the call of the chair.

ATTEST:

Jessica Richardson

Clerk of the Committee